Objectives: Procalcitonin (PCT) is a 13 kD protein of which plasma levels are strongly increased in inflammatory states. PCT-levels are claimed to have a more powerful discriminatory value for bacterial infection than the acute phase proteins serum amyloid A (SAA) or C-reactive protein (CRP). The source of production and its mechanism of induction are unknown. We investigated the inducibility of PCT both in vivo and in vitro, and compared PCT's behavior with SAA and CRP. Design: A prospective descriptive patient sample study and a controlled liver tissue culture study. Setting: A university hospital. Patients: Cancer patients who were treated with human tumor necrosis factor α (rhTNFα; 5 patients) or interleukin-6 (rhIL-6; 7 patients). Measurements and Main results: Serial serum samples were collected for analysis of levels of PCT, SAA and CRP. In the TNFα group frequent sampling was performed on the first day to allow analysis of initial responses. In a human liver slice model the release of PCT, SAA and CRP was measured upon induction with rhTNFα and rhIL-6 for 24 hours. We found that in vivo, after administration of both rhTNFα and rhIL-6, PCT displayed acute phase reactant behavior. After rhTNFα-administration PCT reached half-maximal levels within 8 hours, 12 hours earlier than either SAA or CRP. In vitro PCT, SAA and CRP were produced in detectable quantities by liver tissue. PCT production by liver slices was enhanced after stimulation with rhTNFα or rhIL-6; SAA and CRP levels were elevated after stimulation with rhTNFα. Conclusions: We found that PCT and acute phase proteins such as CRP are induced by similar pathways. The liver appears to be a major source of PCT-production. Thus PCT may be considered an acute phase protein. PCT's different kinetics, and not a fundamentally different afferent pathway may explain its putative diagnostic potential to discriminate bacterial infection from other causes of inflammation.
INTRODUCTION
Any significant inflammatory process is associated with an acute phase response including the production of a broad range of effector proteins such as coagulation factors and protease inhibitors. Acute phase proteins (APP) such as the archetypal C-reactive protein (CRP) are elevated in a manner proportional to the extent of the inflammatory process. The cytokines tumor necrosis factor α (TNFα), interleukin-6 (IL-6) and interleukin-1 have been identified as pivotal in the induction of APPs. Although the theoretical benefits of measuring plasma cytokine levels are obvious, in clinical practice only APPs such as CRP serve to "quantify" inflammation. The short half-life (minutes to hours) of cytokines makes relatively infrequent measurements uselesscertainly if elaborate assay procedures are involved. It has been shown that cytokine levels are higher in bacteraemia, but clinically it has proven difficult to discriminate causes of inflammation on the basis of patterns of cytokine or APP responses. In many patients with fever, it is of paramount importance to discriminate bacterial causes from other causes of inflammation.
It has been claimed that the serum level of the protein procalcitonin (PCT; 116 amino acids; 13 kD) is superior to APPs in differentiating infectious from non-infectious causes of inflammation [1] . PCT levels are proportional to the inflammatory stimulus and elevated levels are detectable within 6 hours after the insult and subsequently decrease with a half-life of about one day [2] . The dynamic range of PCT is very large: in a healthy person PCT-levels are lower than 0.5 µg/L but in septic patients PCT-levels of up to 1000 µg/L have been measured. In the differentiation of infected from non-infected pancreatitis PCT was better than CRP [3] . Likewise in one study PCT appeared better than CRP in detecting bacterial infection in patients with autoimmune disease [4] . On the basis of these results it has been suggested that, in contrast to APPs, PCT is induced directly by endotoxin without intervening cytokines [2] . Induction of PCT after injection of endotoxin has been demonstrated in human volunteers [5] , but the role cytokines play is unknown. Many basic questions about PCT are still unanswered. The question which tissue or organ produces PCT has not been addressed. Mainly based on the fact that PCT is a precursor of calcitonin, a neuro-endocrine origin has been assumed -but not found. Likewise the mechanism of induction is unknown. We hypothesized that, analogous to acute phase proteins, PCT is produced by the liver and induced by TNFα and IL-6 in the absence of endotoxin
In two in vivo studies we investigated whether rhTNFα and rhIL-6 administered to patients can directly induce PCT. In vitro, the production of PCT by human liver tissue, and its inducibility by rhTNFα and rhIL-6 were assessed. In vivo as well as in vitro we compared PCT with serum amyloid A (SAA) and CRP, since SAA and CRP are the fastest responding APPs. The first study concerned patients treated with hyperthermic isolated limb perfusion with rhTNFα [6] . Due to leakage of rhTNFα to the systemic circulation these patients display an intense shortlived systemic inflammatory response [7] . The second study concerned cancer patients who received rhIL-6 as a hematopoietic growth factor [8] .
In the in vitro study we used precision-cut liver slices, which are extensively applied in pharmacology and toxicology [9] . Luster et al. [10] have shown that endotoxin in human liver slices induced TNFα and IL-6 release. The inflammatory response of the liver is a multi-cellular phenomenon, involving Kupffer cells, endothelial cells and hepatocytes. In the liver slice all cell types of the liver are retained. Therefore, liver slices are an attractive model to study integrated inflammatory responses.
PATIENTS AND METHODS
In all studies pure E.coli-derived rhTNFα (Boehringer, Ingelheim, Germany) or rhIL-6 (Novartis, Basel, Switzerland) were used. PCT was measured with an immunoluminometric sandwich assay (LUMItest PCT, Brahms Gmbh, Berlin, Germany; certified normal levels <0.5 µg/L; certified detection range >0.08 µg/L [2] ). SAA and CRP were measured with enzyme linked immunosorbent assays [11] . (normal SAA < 2.7 mg/L; normal CRP<2.3 mg/L; detection limit for both assays is 0.001 mg/L).
Patients treated with TNFα or IL-6.
Five patients with nonresectable soft tissue sarcomas of the lower extremity received 90 min of hyperthermic isolated limb perfusion with 4 mg of rhTNFα and melphalan (10 mg/L limb volume) [6] . Systemic serum samples were analyzed for PCT, SAA and CRP at baseline, at 30 and 90 min after start of rhTNFα-perfusion, as well as at 2, 6, 12, 24, 48 and 72 h after termination of perfusion [7] . In a study to define toxicity and effects on hematopoiesis and biochemical parameters, patients with stage III-IV breast cancer or non-small cell lung cancer received rhIL-6 in a constant daily dosage of 0.5 to 20 µg/kg for 7 successive days (first day intravenously; subsequent 6 days subcutaneously) [8] . Of a total of 20 patients, 7 patients with the lowest initial SAA and CRP values were further studied, in order to exclude patients with substantial inflammation before administration of rhIL-6. These patients received rhIL-6 doses of 0.5, 1, 2.5, 2.5, 5, 5 and 20 µg/kg/day respectively. At the start of rhIL-6 administration patients had a good performance status. PCT, SAA and CRP were determined at baseline and after 1, 2, 7 and 14 days respectively. PCT was determined in serum samples that were stored for up to 7 years at -20 o C. SAA and CRP values have been published earlier [8] but a subset of these data are re-used here to facilitate comparison with PCT. Human liver tissue was obtained from redundant material after bipartitioning of livers procured from multi-organ donors. The human livers were handled as described before [12] . From these pieces of liver tissue, cores (diameter 8 mm) were made as previously described, and stored in icecold University of Wisconsin organ preservation solution until slicing. Liver slices (200-300 µm thickness; wet weight 10-14 mg) were prepared with the Krumdieck slicer. The slices were incubated 24 h in 3.2 mL Williams' medium E supplemented to 25 mM glucose and 50 µg/mL gentamicin. The 6-well tissue culture plates were continuously rocked back and forth (90/min) at 37 o C under 95% O 2 and 5% CO 2 . In addition to unstimulated control slices, slices were stimulated with rhTNFα or rhIL-6 (final concentration 15.6 ng/mL) that was added at the start of slice incubation. The liver slices were incubated in triplicate, and both induction studies and controls were performed in slices from three donor livers. PCT, SAA and CRP were measured in the culture medium after 24 h.
Liver slices incubated with
All studies were approved by the medical ethical commission of our hospital. Patients treated with rhTNFα or rhL-6 gave written informed consent. Consent from the legal authorities and from the families concerned was solicited for the explantation of organs for transplantation purposes.
To examine the statistical significance of induction of PCT, SAA and CRP in the two patientgroups, areas under the curve were calculated for each patient after log-transformation. Likewise, in vitro PCT, SAA and CRP results were also log-transformed for statistical analysis. Student's t- test was used to assess the significance of differences. A p-value <0.05 was considered significant.
RESULTS

Patients treated with TNFα or IL-6.
As early as 3.5 h after the start of the rhTNFα-perfusion patients had already mean PCT-levels of 1.3 µg/L compared to baseline levels of less than 0.1 µg/L. PCT rose to a maximal level of 28 µg/L. Maximal SAA and CRP-levels were 392 and 196 mg/L respectively, compared to baseline levels of 1.9 and 0.9 mg/L respectively (Fig. 6.1 ). PCT reached a half-maximal level within 8 h, whereas SAA and CRP reached half-maximal values after 20 h. Stimulation of PCT, SAA and CRP by rhTNFα as assessed by the areas under the curve was significant with a p-value <0.0001. The patients that received rhIL-6 had maximal levels of PCT, SAA and CRP of 7.8 µg/L, 634 mg/L and 196 mg/L respectively, compared to baseline levels of 0.1 µg/L, 6 mg/L and 7 mg/L respectively ( Fig. 6.2) . Stimulation of PCT, SAA and CRP by rhIL-6 as assessed by the areas under the curve was significant with a p-values of 0.02, 0.0004 and 0.0002 respectively. As comparison of Fig. 6 .1 and Fig. 6.2 shows, increased PCT levels after 1 and 2 days were 9 times higher in the TNFα group than in the IL-6 group.
Liver slices incubated with TNFα or IL-6.
After incubation of the liver slices unstimulated mean (±SEM) production of PCT (0.4±0.2 µg/L), SAA (0.27±0.06 mg/L) and CRP (0.52±0.09 mg/L) could be detected. Synthesis of PCT was increased by stimulation with rhTNFα and rhIL-6 to 274 (p=0.008) and 223 percent (p=0.001) of control levels respectively. rhTNFα induced significant increases in SAA and CRP production to 194 percent (p=0.02) and 147 percent (p=0.03) (Fig. 6.3) ; increases of SAA and CRP after rhIL-6 were not significant (p=0.13 and p=0.24 respectively).
DISCUSSION
To our knowledge this is the first study to demonstrate PCT induction in vivo after administration of TNFα or IL-6. In addition this is the first study to show that PCT was produced by liver tissue in vitro after stimulation with TNFα or IL-6. In vivo PCT has a unique time response. The early rise of PCT we observed after the administration of TNFα was as rapid as observed by Dandona et al. after endotoxin administration [5] . When compared to SAA and CRP the rise of PCT occurred 12 h earlier, with a subsequent fall in circulating levels that is comparable to the fall of SAA or CRP levels. In vitro, after stimulation with TNFα the levels of PCT, SAA and CRP were all increased above control values. The fact that no significant increase in SAA and CRP was found after stimulation with IL-6, is in accordance with the concept of cytokine-specific APP-activation: in vitro socalled type I APPs such as SAA and CRP are preferentially induced by TNFα or IL-1, whereas type II APPs such as fibrinogen are preferentially induced by IL-6 [13] . However, for PCTinduction, under the culture conditions used, no such selectivity was observed. When comparing responses it is important to realise that differences found in PCT release in vivo and in vitro may still be related to a dose dependency of the induction by TNFα and IL-6.
PCT offers interesting opportunities for further study in the liver slice model, since in vitro PCTlevels were far above the detection threshold of the commercial PCT-assay we used. Since endotoxin can induce cytokines in liver slices [10] , it needs to be verified if endotoxin can induce PCT in liver slices, possibly by signalling between the different cell types present in the liver slice. Such an integrated in vitro model may offer possibilities to study intervention in the inflammatory cascade as it occurs in the human liver. It is not necessary to postulate that PCT is principally induced by endotoxin. In fact, a recent study in trauma patients showed that PCT and CRP were related to inflammation caused by injury and were not related to infection [14] . Early sampling after the onset of inflammation and the initially discordant responses of PCT and CRP (or SAA) may explain why some studies revealed a better association of infection with PCT than CRP, whereas a recent study showed that PCT was not a better predictor than CRP for infection [15] . In estimating the sensitivity and specificity of elevated PCT in regard to serious inflammation it is also important to carefully define normal values. PCT's normal upper limit may well be much lower than the 0.5 µg/L value currently used [2] , since others report a PCT-level of only 0.003 µg/L in pooled serum from 13 healthy individuals [16] . Although neither "acute phase protein" nor "acute phase response" has been uniformly defined [13] , we think PCT should seriously be considered an APP since it increases sharply after inflammation, it is produced by liver tissue and it can be induced by TNFα or IL-6. The half-life of elevated PCT-levels of about one day is also characteristic for APPs. As nearly all APPs are synthesized in hepatocytes, this still needs to be verified for PCT, since we only measured PCT in a system containing multiple cell types (i.e. hepatocytes, endothelial cells and Kupffer cells). Whether PCT qualifies as an APP will ultimately depend on the clarification of its function. Recent experiments by Nylen and colleagues with a peritonitis model in Syrian hamsters showed excess mortality after administration of PCT [17] . However, this study is hampered by the use of human PCT in animals, the use of non-specific antibodies and mortality differences between control groups [18] . If PCT turns out to have a paracrine or endocrine function it might be a cytokine, if PCT has effector functions (e.g. protease inhibition) it belongs to the APP-family. In conclusion, our results as well as those published by others strongly suggest that PCT is an APP. Irrespective of PCT's unidentified function, its unique kinetics compared with both acute phase proteins and with cytokines may establish PCT as a particularly useful parameter of inflammation in critical care areas.
